Recent Progresses on Osteoporotic Refractures in the Elderly

doi:10.12114/j.issn.1007-9572.2020.00.529

Abstract

Abstract: Osteoporosis is a prevalent disease in the elderly. It has become a prominent public health problem in China with rapid population aging. Fracture is the most serious outcome of osteoporosis. Elderly patients with osteoporotic fractures are prone to recurrent fractures，which are major barriers to healthy aging due to induced difficulty in functional recovery，reduced quality of life and increased morbidity and mortality. The purpose of this review is to systematically examine recent literature regarding the risk factors，risk assessment and intervention for recurrence of osteoporotic fractures in the elderly，providing a basis for developing strategies for osteoporotic refractures in this group.

Key words: Osteoporosis, Osteoporosis fracture, Aged, Review

摘要： 骨质疏松症在老年人中普遍存在，随着我国人口老龄化的加剧，骨质疏松症成为我国突出的公共卫生问题之一。骨折是骨质疏松症的最严重后果，老年骨质疏松性骨折易再发骨折。再发骨折会造成老年人功能恢复困难、生活质量下降、致残率与死亡率增加，已成为阻滞健康老龄化进程的主要问题。本文从老年骨质疏松性骨折再发的危险因素、风险识别、干预等方面进行综述，以有效指导临床医护人员制定再发骨折预防方案，减少再发骨折的发生。

关键词: 骨质疏松症, 骨质疏松性骨折, 老年人, 综述

ZHANG Huaguo,SONG Mi,XU Yue, et al. Recent Progresses on Osteoporotic Refractures in the Elderly　[J]. Chinese General Practice, 2021, 24(7): 886-889. DOI: 10.12114/j.issn.1007-9572.2020.00.529.
张华果,宋咪,徐月等. 老年骨质疏松性骨折再发的研究进展[J]. 中国全科医学, 2021, 24(7): 886-889. DOI: 10.12114/j.issn.1007-9572.2020.00.529.

References

［1］罗令，孙晓峰，皮丕喆，等．近10年来我国中老年人群骨质疏松症患病率的荟萃分析［J］．中国骨质疏松杂志，2018，24（11）：1415-1420．DOI：10.3969/j.issn.1006-7108.2018.11.004.
［2］MITCHELL P，?KESSON K，CHANDRAN M，et al．Implementation of models of care for secondary osteoporotic fracture prevention and orthogeriatric models of care for osteoporotic hip fracture［J］．Best Practice Research Clinical Rheumatology，2016，30（3）：536-558．DOI：10.1016/j.berh.2016.09.008.
［3］邱贵兴，裴福兴，胡侦明，等．中国骨质疏松性骨折诊疗指南（全文）（骨质疏松性骨折诊断及治疗原则）［J］．中华关节外科杂志：电子版，2015，9（6）：795-798．
［4］BLIUC D，ALARKAWI D，NGUYEN T V，et al．Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density：the dubbo osteoporosis epidemiology study［J］．J Bone Miner Res，2015，30（4）：637-646．DOI：10.1002/jbmr.2393.
［5］KLOP C，VAN STAA T P，COOPER C，et al．The epidemiology of mortality after fracture in England：variation by age，sex，time，geographic location，and ethnicity［J］．Osteoporos Int，2017，28（1）：161-168．DOI：10.1007/s00198-016-3787-0.
［6］邱贵兴，裴福兴，胡侦明，等．中国骨质疏松性骨折诊疗指南——骨质疏松性骨折诊断及治疗原则［J］．黑龙江科学，2018，9（2）：85-88，95．DOI：CNKI:SUN:HELJ.0.2018-02-029.
［7］黄天霁，寇玉辉，殷晓峰，等．椎体强化术后再发椎体骨折的临床特点和危险因素［J］．北京大学学报（医学版），2015，47（2）：237-241．DOI：10.3969/j.issn.1671-167X.2015.02.009.
［8］郭素云，桂辉琼，彭雪金．骨质疏松性骨折健康教育对二次骨折的影响研究［J］．护理实践与研究，2016，13（5）：53-54．DOI：10.3969/j.issn.1672-9676.2016.05.023．
［9］眭文洁，陈小康，陆秀珍，等．老年患者再发骨质疏松性骨折的发病特点［J］．中国老年学杂志，2014，34（16）：4624-4625．DOI：10.3969/j.issn.1005-9202.2014.16.099．
［10］刘强．骨质疏松症与骨质疏松性骨折［J］．中华创伤杂志，2015，31（9）：793-795．DOI：10.3760/cma.j.issn.1001-8050.2015.09.008.
［11］SI L，WINZENBERG T M，JIANG Q，et al．Projection of osteoporosis-related fractures and costs in China：2010—2050［J］．Osteoporos Int，2015，26（7）：1929-1937．
［12］CUI L，CHEN L，XIA W，et al．Vertebral fracture in postmenopausal Chinese women：a population-based study［J］．Osteoporos Int，2017，28（9）：2583-2590．
［13］梁玉柱，郭洪刚．老年骨质疏松性髋部骨折：昨天、今天及未来［J］．中国组织工程研究，2017，21（15）：2438-2443．
［14］陈阳，马剑雄，马信龙．老年性骨质疏松骨折研究进展［J］．
中国骨质疏松杂志，2011，17（9）：835-839．DOI：10.3969/j.issn.1006-7108.2011.09.022.
［15］BANEFELT J，?KESSON K E，SP?NGEUS A，et al．Risk of imminent fracture following a previous fracture in a Swedish database study［J］．Osteoporosis International，2019，30：601-609．DOI：10.1007/s00198-019-04852-8.
［16］ZHU Y，CHEN W，SUN T，et al．Meta-analysis of risk factors for the second hip fracture（SHF） in elderly patients［J］．Arch Gerontol Geriatr，2014，59（1）：1-6．
［17］BYNUM J P W，BELL J E，CANTU R V，et al．Second fractures among older adults in the year following hip，shoulder，or wrist fracture［J］．Osteoporosis International，2016，27（7）：2207-2215．DOI：10.1007/s00198-016-3542-6.
［18］LAWRENCE T M，WENN R，BOULTON C T，et al．Age-specific incidence of first and second fractures of the hip［J］．Bone & Joint Journal，2010，92（2）：258-261．
［19］HAGINO H，SAWAGUCHI T，ENDO N，et al．The risk of a second hip fracture in patients after their first hip fracture［J］．Calcified Tissue International，2012，90（1）：14-21．
［20］叶向阳，汤立新，程省，等．骨密度对骨质疏松性椎体压缩性骨折PKP术后骨折再发风险的评估价值［J］．中国骨质疏松杂志，2017，23（2）：154-158．DOI：10.3969/j.issn.1006-7108.2017.02.004.
［21］JARVINEN T L，MICHAELSSON K，ASPENBERG P，et al．Osteoporosis：the emperor has no clothes［J］．J Intern Med，2015，277（6）：662-673．DOI：10.1111/joim.12366.
［22］SILVA B C，LESLIE W D，RESCH H，et a1．Trabecular bone score：a noninvasive analytical method based upon the DXA image［J］．Journal of Bone and Mineral Research，2014，29（3）：518-530．DOI：10.1002/jbmr.2176.
［23］林园园，董进，夏维波．高分辨外周骨定量CT的临床应用［J］．中华骨质疏松和骨矿盐疾病杂志，2016，9（4）：409-415．
［24］IMAI K．Recent methods for assessing osteoporosis and fracture risk［J］．Recent Pat Endocr Metab Immune Drug Discov，2014，8（1）：48-59．DOI：10.2174/1872214808666140118223801.
［25］张平．基于定量CT的有限元分析在骨质疏松领域研究进展［J］．实用放射学杂志，2019，35（2）：312-314．DOI：10.3969/j.issn.1002-1671.2019.02.036.
［26］VASIKARANA S，EASTELL R，BRUYERE O，et al．Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment：a need for international reference standards［J］．Osteoporosis International，2011，22（2）：391-420．DOI：10.1007/s00198-010-1501-1.
［27］JOHANSSON H，ODEN A，KANIS J A，et al．A meta-analysis of reference markers of bone turnover for prediction of fracture［J］．Calcified Tissue International，2014，94（5）：560-567．DOI：10.1007/s00223-014-9842-y.
［28］GERDHEM P，IVASKA K K，ALATALO S L，et al．Biochemical markers of bone metabolism and prediction of fracture in elderly women［J］．J Bone Miner Res，2004，19（3）：386-393．DOI：10.1359/JBMR.0301244.
［29］MEIER C，NGUYEN T V，CENTER J R，et al．Bone resorption and osteoporotic fractures in elderly men：the Dubbo Osteoporosis Epidemiology Study［J］．J Bone Miner Res，2005，20（4）：579-587．DOI：10.1359/JBMR.041207.
［30］BAUER D C，GARNERO P，HARRISON S L，et al．Biochemical markers of bone turnover，hip bone loss，and fracture in older men：the MrOS study［J］．J Bone Miner Res，2009，24（12）：2032-2038．DOI：10.1359/jbmr.090526.
［31］中华医学会骨质疏松和骨矿盐疾病分会．原发性骨质疏松症诊疗指南（2017）［J］．中华骨质疏松和骨矿盐疾病杂志，2017，10（5）：413-444．
［32］DONALDSON M G，PALERMO L，ENSRUD K E，et al．Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density：the fracture intervention trial［J］．Journal of Bone and Mineral Research，2012，27（8）：1804-1810．
［33］ETTINGER B，ENSRUD K E，BLACKWELL T，et al．Performance of FRAX in a cohort of community-dwelling，ambulatory older men：the Osteoporotic Fractures in Men（MrOS） study［J］．Osteoporosis International，2013，24（4）：1185-1193．DOI：10.1007/s00198-012-2215-3.
［34］ENSRUD K E，TAYLOR B C，PETERS K W，et al．Implications of expanding indications for drug treatment to prevent fracture in older men in United States：cross sectional and longitudinal analysis of prospective cohort study［J］．BMJ，2014，349：4120．DOI：10.1136/bmj.g4120.
［35］ROUS S，CABANA F，CARRIER N，et al．The World Health Organization Fracture Risk Assessment Tool（FRAX） underestimates incident and recurrent fractures in consecutive patients with fragility fractures［J］．J Clin Endocrinol Metab，2014，99（7）：2400-2408．DOI：10.1210/jc.2013-4507.
［36］OUDSHOORN C，HARTHOLT K A，ZILLIKENS M C，et al．Emergency department visits due to vertebral fractures in the Netherlands，1986—2008：steep increase in the oldest old，strong association with falls［J］．Injury，2012，43（4）：458-461．DOI：10.1016/j.injury.2011.09.014.
［37］鲍小刚，刘佳，牛东阳，等．高龄、跌倒、骨密度对老年脊柱骨折预测的价值分析［J］．中国骨质疏松杂志，2019，25（12）：1696-1699．
［38］KOH L K，SEDRINE W B，TORRALBA T P，et al．A simple tool to identify Asian women at increased risk of osteoporosis［J］．Osteoporos Int，2001，12：699-705．DOI：10.1007/s001980170070.
［39］申浩．基于Cox比例风险模型的绝经后骨质疏松症骨折早期风险预测工具研究［D］．北京：中国中医科学院，2014.
［40］GUYEN N D，FROST S A，CENTER J R，et al．Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks［J］．Osteoporos Int，2008，19（10）：1431-1444．DOI：10.1007/s00198-008-0588-0.
［41］章轶立，魏戌，申浩，等．骨质疏松性骨折诊断技术与风险预测工具研究进展［J］．中国骨质疏松杂志，2018，24（5）：676-680．DOI：10.3969/j.issn.1006-7108.
［42］MORELL S，HEMMELER C，AMSLER F，et al．Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture—a Swiss trauma center secondary prevention project［J］．Swiss Med Wkly，2017，147：w14451．DOI：10.4414/smw.2017.14451.
［43］弥娟妮，王丽萍，朱晔，等．绝经后骨质疏松性再骨折医患联合延续性健康教育效果评价［J］．预防医学，2019，31（9）：963-966．DOI：10.19485/j.cnki.issn2096-5087.2019.09.028．
［44］高远，屈波，孔丹，等．护理干预减少老年髋部骨折术后再骨折的随机对照研究［J］．解放军医学院学报，2015，36（6）：614-617．DOI：10.3969/j.issn.2095-5227.2015.06.025.
［45］AKESSON K，MARSH D，MITCHELL PJ，et al．Capture the fracture：a best practice framework and global campaign to break the fragility fracture cycle［J］．Osteoporos Int，2013，24：2135-2152．DOI：10.1007/s00198-013-2348-z.
［46］AUBRY-ROZIER B，STOLL D，GONZALEZ R E，et al．Impact of a fracture liaison service onpatient management after an osteoporotic fracture：the CHUV FLS［J］．Swiss Med Wkly，2018，148：w14579．DOI：10.4414/smw.2018.14579.
［47］肖恩，邓忠良，李毅中，等．骨质疏松骨折二级预防之骨折联络员模式探讨华南/华西区骨科专家研讨会议纪要［J］．中华关节外科杂志：电子版，2015，9（5）：673-675．
［48］林华．骨质疏松性骨折的临床评估和术后干预［J］．中华骨质疏松和骨矿盐疾病杂志，2017，10（1）：2-6．
［49］刘春香，成传芳，赵晨，等．骨折联络服务在老年髋部脆性骨折患者中的应用［J］．中华护理杂志，2019，54（9）：1343-1348．DOI：10.3761/j.issn.0254-1769.2019.09.012.
［50］刘朝露．FLS模式在OVCF患者中的应用研究［D］．遵义：遵义医学院，2018.
［51］麻新灵，夏海鸥，王金花．骨质疏松性骨折应对策略——骨折联络服务研究进展及应用探讨［J］．中国骨质疏松杂志，2019，25（11）：1645-1649，1658．DOI：10.3969/j.issn.1006-7108.2019.11.029.

[1]	FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358.
[2]	GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238.
[3]	WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335.
[4]	YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172.
[5]	WANG Xu, WEI Xu, ZHU Liguo, FENG Tianxiao, WANG Zhipeng, SHI Bin. Research Ideas of the Efficacy Mechanism and Prospect Analysis of Traditional Chinese Manipulative Therapy on Treating Spinal Degenerative Diseases with Combination of Medicine and Industry [J]. Chinese General Practice, 2023, 26(33): 4118-4124.
[6]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[7]	ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117.
[8]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[9]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[10]	MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102.
[11]	CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895.
[12]	ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889.
[13]	DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907.
[14]	WANG Jiaxin, ZHAO Yali. Domestic and International Assessment Tools for Medical Teamwork: a Systematic Review [J]. Chinese General Practice, 2023, 26(31): 3951-3962.
[15]	XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840.